Aurobindo Pharma Q4 net almost flat at ₹903 crore
The Hindu
Aurobindo Pharma's net profit declines slightly, but revenue and total expenses show significant growth in March quarter.
Generic drugmaker Aurobindo Pharma reported consolidated net profit for the March quarter declined marginally to ₹903 crore compared with ₹907 crore a year earlier.
The lower net profit came on a 10.6% increase in revenue from operations to ₹8,382 crore (₹7,580 crore) and total expenses rising more than 12% to ₹7,149.6 (₹6,351.1 crore).
Formulations revenue from the key U.S. market increased 13.5% YoY to ₹4,072 crore, while in Europe it rose 17.2% to ₹2,147 crore. Growth Markets formulations revenue declined 7.8% to ₹786 crore.
Total formulations revenue at ₹7,313 crore (₹6,510 crore) was an increase of 12.3%. Total API revenue was 5% higher at ₹1,069 crore (₹1,019 crore).
It was another quarter and year of all-time high sales and EBITDA, “reflecting the strength of our core businesses, consistent volume-led growth and the depth of our differentiated product portfolio,” vice-chairman and MD K. Nithyananda Reddy said.
Aurobindo’s European operations continue to perform exceptionally well and moving steadily towards the $1-billion revenue milestone. “Backed by our ongoing capacity enhancements we remain firmly positioned to sustain our trajectory,” he said in a release.
For the fiscal ended March, the company’s consolidated revenue from operations was 9.4% higher at ₹31,724 crore (₹29,002 crore). Net profit increased 9.9% to ₹3,484 crore (₹3,169 crore).
Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.
The Rupee appreciated by 19 paise to close at 89.96 against the U.S. dollar amid weak dollar index support.
India aims to expand its tea exports to China, highlighting diverse varieties like Darjeeling and Masala at a recent buyer-seller meet.
Stock markets rebound after four days of decline as Sensex rises 158 points, driven by tech and IT shares.
India reduces Russian oil imports by 38% in October 2025, marking the sharpest decline in value and volume yet.
Suzlon announces three new AI-enabled smart blade factories, expanding its manufacturing footprint to 20 facilities in India.
Odisha Government terminates Silicon Tech Lab's empanelment for involvement in a recruitment scam and service agreement violations.
Worli, Mumbai, dominates India’s ultra-luxury apartment market, accounting for 40% of transactions worth ₹5,500 crore in two years.
IndiGo faces disruptions due to a hiring freeze, prompting pilots' body to urge regulatory intervention for safe operations.
Nvidia CEO Jensen Huang met separately with U.S. President Donald Trump and Republican senators Wednesday
Rupee falls to 90.43 against the dollar amid RBI's restrained intervention and high importer demand, causing market concerns.
Meta’s poaching of Apple's Alan Dye underscores its push to expand consumer hardware beyond its smart glasses
Airbus orders upgrades for 6,000 A320 aircraft after a JetBlue incident raises concerns about software vulnerability to solar radiation.